Biomedical Review Board

The latest drugs are targeting specific tumor weaknesses with better results and less side effects.

FDA approves lifileucel (Amtagvi), the first-ever TIL cellular therapy for advanced melanoma.

Gut bacteria can predict and improve cancer treatment response.

Exercise and diet are now key clinical strategies for cancer survivors.

Cutting through the 'Frequency Forest' wellness trend to reveal what the facts are.

Movement helps cancer survivors reduce fatigue and improve recovery.

Primary physicians now lead long-term cancer survivor care.

Young cancer survivors face more social and financial instability.

Hearing directly from people with lived experience is key to improving care